- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Venus Concept Inc (VERO)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: VERO (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $10.6
1 Year Target Price $10.6
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -81.1% | Avg. Invested days 16 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 2.90M USD | Price to earnings Ratio - | 1Y Target Price 10.6 |
Price to earnings Ratio - | 1Y Target Price 10.6 | ||
Volume (30-day avg) 1 | Beta -0.04 | 52 Weeks Range 1.42 - 8.93 | Updated Date 01/10/2026 |
52 Weeks Range 1.42 - 8.93 | Updated Date 01/10/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -45.26 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -92.76% | Operating Margin (TTM) -68.93% |
Management Effectiveness
Return on Assets (TTM) -32.43% | Return on Equity (TTM) -794.55% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 31254231 | Price to Sales(TTM) 0.05 |
Enterprise Value 31254231 | Price to Sales(TTM) 0.05 | ||
Enterprise Value to Revenue 0.53 | Enterprise Value to EBITDA -3.16 | Shares Outstanding 1859123 | Shares Floating 1624372 |
Shares Outstanding 1859123 | Shares Floating 1624372 | ||
Percent Insiders 0.82 | Percent Institutions 15.73 |
Upturn AI SWOT
Venus Concept Inc

Company Overview
History and Background
Venus Concept Inc. was founded in 2007. It is a global leader in the medical aesthetics industry, focused on delivering non-invasive and minimally invasive aesthetic treatments. The company has grown through organic expansion and strategic acquisitions, building a portfolio of innovative technologies and a strong global distribution network.
Core Business Areas
- Medical Aesthetics Devices: Venus Concept develops, manufactures, and sells a range of advanced medical aesthetic devices for hair removal, skin tightening, body contouring, and wrinkle reduction. These devices utilize proprietary technologies such as radiofrequency (RF), magnetic pulses, and light-based systems.
- Consumables and Services: The company also generates revenue from the sale of related consumables (e.g., handpieces, gels) and offers service and maintenance plans for its devices, ensuring ongoing customer support and recurring revenue.
Leadership and Structure
Venus Concept is led by a management team with expertise in the medical aesthetics and technology sectors. The organizational structure is designed to support global sales, marketing, research and development, and customer service operations.
Top Products and Market Share
Key Offerings
- Venus Versau2122: A multi-application platform offering treatments for skin resurfacing, photorejuvenation, and hair removal. Competitors include Cynosure (Hologic), Lumenis, and Candela Medical. Market share data for individual products is not publicly disclosed, but it is a significant contributor to Venus Concept's revenue.
- Venus Freeze Plusu2122 / Venus Legacyu2122: Devices utilizing Radio Frequency (RF) and Magnetic Pulse technology for non-invasive skin tightening and body contouring. Key competitors include BTL Aesthetics, InMode, and Cynosure.
- Venus Vivau2122: A fractional RF system for skin resurfacing and wrinkle reduction. Competitors include Lumenis and Syneron-Candela.
Market Dynamics
Industry Overview
The global medical aesthetics market is experiencing robust growth, driven by increasing consumer demand for non-invasive cosmetic procedures, aging populations, technological advancements, and rising disposable incomes. The market is highly competitive with a mix of established players and emerging companies.
Positioning
Venus Concept is positioned as a comprehensive provider of innovative, science-based aesthetic solutions. Its strengths lie in its proprietary technologies, global commercial infrastructure, and recurring revenue model from consumables and service agreements. The company focuses on delivering both effective treatments and a superior customer experience.
Total Addressable Market (TAM)
The global medical aesthetics market is valued in the tens of billions of dollars and is projected to continue growing. Venus Concept is a significant player within this market, particularly in the non-invasive and minimally invasive segments. Its market share is a fraction of the total TAM, indicating substantial room for growth.
Upturn SWOT Analysis
Strengths
- Proprietary technologies with strong intellectual property.
- Global sales and distribution network.
- Recurring revenue streams from consumables and service contracts.
- Focus on research and development for new product innovation.
- Strong brand recognition in the medical aesthetics industry.
Weaknesses
- Reliance on a relatively concentrated product portfolio.
- Competition from larger, more diversified medical device companies.
- Potential for longer sales cycles for high-ticket devices.
- Sensitivity to economic downturns affecting discretionary spending.
Opportunities
- Expansion into emerging markets with growing demand for aesthetic procedures.
- Development of new applications for existing technologies.
- Strategic partnerships and acquisitions to broaden product offerings.
- Increasing consumer awareness and acceptance of non-invasive treatments.
- Growth in the male aesthetics market.
Threats
- Intensifying competition and pricing pressures.
- Regulatory changes affecting medical device approvals and marketing.
- Technological obsolescence if innovation falters.
- Economic recessions impacting consumer spending on elective procedures.
- Adverse publicity related to aesthetic procedures.
Competitors and Market Share
Key Competitors
- Cynosure, LLC (Part of Hologic, Inc.) (HOLX)
- Lumenis Ltd.
- Candela Medical
- BTL Aesthetics
- InMode Ltd. (INMD)
Competitive Landscape
Venus Concept competes in a dynamic market. Its advantages include a strong focus on scientific validation and proprietary technologies. However, it faces challenges from larger, well-established competitors with broader product lines and greater financial resources. The company's ability to innovate and effectively market its solutions will be crucial for maintaining and growing its market position.
Growth Trajectory and Initiatives
Historical Growth: Venus Concept has demonstrated a trajectory of growth, expanding its product portfolio and global footprint. Growth has been fueled by market penetration, new product introductions, and an increasing number of practitioners adopting their technologies.
Future Projections: Future growth is expected to be driven by continued innovation, expansion into new geographic markets, and increasing demand for aesthetic treatments. Analysts typically project mid-to-high single-digit or low double-digit revenue growth, contingent on market dynamics and competitive pressures. (Note: Specific analyst projections require access to current analyst reports).
Recent Initiatives: Recent initiatives likely include the launch of new devices or enhancements to existing platforms, strategic partnerships, and efforts to optimize sales and distribution channels to drive market penetration and revenue growth.
Summary
Venus Concept Inc. is a notable player in the growing medical aesthetics market, distinguished by its innovative technologies and global reach. Its recurring revenue model and focus on R&D are strengths, but it faces significant competition. The company must continue to innovate and expand its market presence to capitalize on the substantial total addressable market and navigate potential economic headwinds.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company's Investor Relations website
- SEC Filings (10-K, 10-Q)
- Industry Research Reports
- Financial News Outlets
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It does not constitute investment advice. Financial data and market share estimations are subject to change and may vary depending on the source and reporting period.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Venus Concept Inc
Exchange NASDAQ | Headquaters Toronto, ON, Canada | ||
IPO Launch date 2012-11-05 | CEO & Director Mr. Rajiv Kanishka Liyanaarchchie De Silva | ||
Sector Healthcare | Industry Medical Devices | Full time employees 292 | Website https://www.venus.ai |
Full time employees 292 | Website https://www.venus.ai | ||
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

